Rep. Judy Chu

Maddy summaryHRES 856 is a non-binding resolution expressing the House of Representatives' view that the U.S. Department of Agriculture (USDA) should use its existing contingency funds and interchange authority to fund the Supplemental Nutrition Assistance Program (SNAP) for November 2025. The resolution cites that the USDA holds over $5 billion in contingency funds set aside for emergencies and has legal authority under the Department of Agriculture Organic Act to transfer funds between nutrition programs to maintain SNAP benefits. This would directly support approximately 42 million people relying on SNAP, including 16 million children, 8 million seniors, 4 million people with disabilities, and 1.2 million veterans, preventing disruption during a potential funding gap. The resolution does not create new law but urges the administration to use existing resources to ensure continued food assistance.

Maddy summaryThis bill grants posthumous U.S. citizenship to noncitizens who served honorably in the U.S. military during World War II while enlisted in the Philippines and died between September 1, 1939, and December 31, 1946. It amends the Immigration and Nationality Act to include these veterans under specific eligibility criteria: they must have died from service-related injuries or diseases, and met enlistment requirements during that historical period. The bill removes barriers by clarifying that the standard naturalization requirements (section 319(d)) and related provisions (section 1703 of the 2004 Defense Act) do not apply to this group. This allows descendants to petition for citizenship on behalf of qualifying deceased service members through a certification from the relevant military department.

Maddy summaryThe Artificial Intelligence Civil Rights Act of 2025 requires developers and deployers of AI systems that make decisions affecting "consequential actions" (such as employment, housing, healthcare, education, and credit) to conduct pre-deployment evaluations and annual impact assessments by independent auditors. The bill mandates transparency requirements including clear disclosures to individuals about how AI is used in decision-making, establishes a right to human alternatives for significant AI-driven decisions, and prohibits discrimination based on protected characteristics like race, gender, or disability. It creates enforcement mechanisms through the Federal Trade Commission, state attorneys general, and private lawsuits, with penalties including civil penalties of up to 4% of annual revenue. The act also requires developers to provide explanations for AI-driven decisions and sets standards for data collection to prevent harm and ensure fairness in critical life areas.

Maddy summaryHR 6358, the Veteran Education Empowerment Act, creates a federal grant program to help colleges establish or improve dedicated Student Veteran Centers. These centers provide veterans, active-duty service members, and their families with lounge space, benefits counseling, academic support, and mental health services. Institutions must serve significant numbers of veterans and have sustainability plans to qualify for grants, with funding capped at $500,000 per institution over four years. The bill directly affects colleges serving veterans and aims to address challenges like isolation and transition difficulties through centralized campus support.

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Maddy summaryThis bill establishes a federal program to help low-income households pay for drinking water and wastewater services. It provides $500 million annually (2026-2030) in grants to states and tribes that already administer energy assistance programs, allowing them to cover past-due bills or other costs for households meeting specific income criteria (e.g., receiving certain federal benefits or earning ≤150% of the poverty level). The program prohibits using these funds to replace existing assistance and requires technical help to streamline eligibility. It directly affects low-income households in participating states and tribes, particularly those facing water affordability challenges.

Maddy summaryHRES 899 is a symbolic House resolution recognizing the Transgender Day of Remembrance and memorializing transgender people killed by violence in 2024-2025. It directly affects transgender individuals, particularly transgender women of color, by acknowledging the epidemic of violence against them - citing 27 U.S. victims (including names like Rick Alastor Newman and Kyla Jane Walker) and 241 global cases in 2025. The resolution’s key provisions include formally recognizing the violence epidemic, memorializing specific lives lost, and affirming the need for solutions to protect transgender people. It does not create new laws but expresses congressional support for addressing systemic violence and discrimination faced by transgender communities.

Maddy summaryHR 6215, the Small Business RELIEF Act, exempts small businesses from import duties imposed under Executive Order 14257 (90 Fed. Reg. 15041) for goods they import or use. It requires the President to refund duties paid by small businesses within 90 days of the bill's enactment. The bill defines "small business concern" using the standard Small Business Act criteria (15 U.S.C. 632). This directly affects small businesses importing goods, providing immediate cost relief by removing a specific tariff and refunding past payments.

Maddy summaryThe ADOPT Act of 2025 creates federal offenses to prevent exploitation in private domestic interstate adoptions. It prohibits unlicensed groups from acting as intermediaries between birth parents and adoptive parents, restricts certain adoption advertising, and caps payments to birth parents at $2,500 before consulting a licensed agency or attorney. The bill directly affects unlicensed adoption facilitators, birth parents, and prospective adoptive parents by requiring all adoption services to occur through licensed providers or exempt entities like attorneys and nonprofit agencies. Violations carry fines up to $100,000 for organizations or $50,000 plus 5 years in prison for individuals, with exemptions for public agencies, licensed child-placing organizations, and attorneys.

Maddy summaryThis bill expands Medicare's drug price negotiation program to cover 50 drugs (up from 20) and requires health insurers to apply negotiated prices to cost-sharing for beneficiaries. It establishes annual out-of-pocket cost-sharing limits for prescription drugs under group health plans and insurance coverage, with specific limits of $2,000 for self-only coverage in 2027 that will increase annually. The bill also sets specific cost-sharing limits for insulin products, requiring coverage with no deductible and cost-sharing of no more than $35 per 30-day supply or 25% of the negotiated price. These provisions affect Medicare beneficiaries, people with group health plans, and health insurers across the country. The bill applies to plan years beginning on or after January 1, 2027.